The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial
Background: Restless legs syndrome (RLS) affects approximately 30% of patients with end-stage kidney disease and is associated with impaired sleep and health-related quality of life. Medications used to treat RLS in patients receiving dialysis may have an increased risk of adverse events with dose t...
Main Authors: | David Collister, Kayla Pohl, Gwen Herrington, Shun Fu Lee, Christian Rabbat, Karthik Tennankore, Deborah Zimmermann, Navdeep Tangri, Ron Wald, Braden Manns, Rita S. Suri, Annie-Claire Nadeau-Fredette, Remi Goupil, Samuel A. Silver, Michael Walsh |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-11-01
|
Series: | Canadian Journal of Kidney Health and Disease |
Online Access: | https://doi.org/10.1177/2054358120968959 |
Similar Items
-
Pramipexole in peritoneal dialysis patients with restless legs syndrome (RLS): a protocol for a multicentre double-blind randomised controlled trial
by: Jie Dong, et al.
Published: (2020-02-01) -
Skeletal muscle in Restless legs syndrome (RLS) and Obstructive sleep apnoea syndrome (OSAS)
by: Wåhlin Larsson, Britta
Published: (2009) -
Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemic
by: Romero-Gutierrez, C., et al.
Published: (2022) -
The Effects of a Gentle Yoga Program on Sleep, Mood, and Blood Pressure in Older Women with Restless Legs Syndrome (RLS): A Preliminary Randomized Controlled Trial
by: Kim E. Innes, et al.
Published: (2012-01-01) -
P02.156. Effects of a gentle yoga program on Restless Legs Syndrome (RLS) symptoms and related outcomes in women with RLS: a pilot study
by: Innes K, et al.
Published: (2012-06-01)